Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Systems Approach
100%
Innate Immunity
100%
Alzheime's Disease
93%
Alzheimer's Disease
93%
Prognostic Biomarker
31%
Alzheimer
31%
Transcriptomic Signature
31%
Therapeutic Target
25%
Decliners
25%
Plasma Samples
25%
Transcriptional Changes
18%
Innate Immune Response
18%
Disease Stage
12%
Pathologic
12%
Mayo Clinic Study of Aging
12%
RNA Sequencing (RNA-seq)
12%
Plasma RNA
12%
RNA-sequencing Data
12%
MCI-AD
12%
Progressive Supranuclear Palsy
9%
Molecular Changes
9%
Neurodegeneration
9%
Target Validation
9%
Immune Targets
9%
Transcriptional Network
9%
Validation Studies
9%
Innate Immune Signaling
9%
Alzheimer's Disease Risk
6%
Tau Pathology
6%
Clinical Efficacy
6%
Immunological Pathways
6%
Innovative Analytics
6%
Intent-to-treat
6%
Disease Risk Gene
6%
Tau Amyloid
6%
Drug Target
6%
Disease Knowledge
6%
Mechanism of Action
6%
Immune System
6%
Analytic Approach
6%
Knowledge Gaps
6%
Brain Regions
6%
Molecular Mechanism
6%
Therapeutic Implications
6%
Health-to-disease Transition
6%
Aging
6%
Clinical Testing
6%
Nogo-A
6%
Targeting Mechanism
6%
Scientific Community
6%
Multi-target
6%
Clinical Trials
6%
Living Subjects
6%
Expression Profile
6%
Plasma Transcriptome
6%
Differentially Expressed Pathways
6%
Activation State
6%
Multiple Time Points
6%
MicroRNA
6%
Transcriptome
6%
Differentially Expressed Transcripts
6%
Systems-based Approach
6%
Specific Aims
6%
Brain Tissue
6%
Brain Signature
6%
Expression Network
6%
Brain Transcriptome
6%
PAXgene
6%
Peripheral Blood Mononuclear Cells
6%
Peripheral Tissues
6%
Neuroimaging
6%
NanoString nCounter
6%
Older Subjects
6%
Response to Therapy
6%
Endophenotype
6%
Clinical Manifestations
6%
Total RNA
6%
Biochemistry, Genetics and Molecular Biology
Innate Immunity
95%
Tau
72%
Adenosine Monophosphate
62%
Amyloid Protein
44%
Blood Plasma
31%
Mouse Model
31%
Genetics
20%
Transcriptomics
20%
Molecular Mechanism
18%
Gene Locus
10%
Transgenic Mouse
10%
Postsynaptic Potential
10%
Protein Homeostasis
10%
Genetic Association
10%
TREM2
10%
Gliosis
10%
Signal Transduction
10%
RNA Sequence
8%
Medicine and Dentistry
Innate Immunity
62%
Alzheimer's Disease
62%
Diseases
22%
Tau
19%
Adenosine Phosphate
19%
Therapeutic Target
19%
Amyloid Protein
14%
Progressive Supranuclear Palsy
8%
Brain Region
5%
Intention-to-Treat Analysis
5%
Target Validation
5%
Neurodegeneration
5%
Immune System
5%